Lefamulin

Caitlin Soto, PharmD, BCIDP, Fidelia Bernice, Pharm.D.
Pediatric Dosing Author: Bethany Sharpless Chalk, Pharm.D., BCPPS

INDICATIONS

INDICATIONS

INDICATIONS

FDA

FDA

FDA

  • Treatment of adults with community-acquired bacterial pneumonia (CABP) caused by susceptible microorganisms.

NON-FDA APPROVED USES

NON-FDA APPROVED USES

NON-FDA APPROVED USES

  • No established non-FDA-approved clinical indications.
    • In vitro activity has been demonstrated against MRSA and some isolates of vancomycin-resistant E. faecium and multidrug-resistant N. gonorrhoeae.
    • Limited clinical experience with multidrug-resistant M. genitalium has shown inconsistent efficacy.

There's more to see -- the rest of this topic is available only to subscribers.

© 2000–2026 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.